Genetically modified bacillus subtilis strain and use as a live delivery and production system
US-2024390433-A1 · Nov 28, 2024 · US
Methods of use of probiotic bifidobacteria for human beauty benefits
US8926952B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-8926952-B2 |
| Application number | US-39894306-A |
| Country | US |
| Kind code | B2 |
| Filing date | Apr 6, 2006 |
| Priority date | Apr 8, 2005 |
| Publication date | Jan 6, 2015 |
| Grant date | Jan 6, 2015 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
Methods of use in humans of probiotic bacteria of the genus Bifidobacteria for regulating the condition of human keratinous tissue to achieve cosmetic beauty benefits. Said methods include regulation, either prophylactic or therapeutic, of the cosmetic appearance of human keratinous tissue, such as human hair, skin (e.g., scalp), and nails. In another aspect, the invention provides a method of marketing a composition comprising probiotic Bifidobacteria . In one embodiment, the method comprises: (1) offering for sale a composition comprising probiotic Bifidobacteria ; and (2) communicating to a potential consumer of said composition that oral administration of said composition can regulate the condition of human keratinous tissue.
First claim
Opening claim text (preview).
What is claimed is: 1. A method of regulating the condition of human keratinous tissue, comprising orally administering a probiotic strain of Bifidobacteria to a human seeking said regulation. 2. The method of claim 1 , wherein said Bifidobacteria is isolated from the human gastrointestinal tract. 3. The method of claim 1 , wherein said Bifidobacteria is selected from the group consisting of Bifidobacteria having accession numbers NCIMB 41050, NCIMB 41051, NCIMB 41052, NCIMB 41053, NCIMB 41099, NCIMB 41100, NCIMB 41003, mutants thereof, and mixtures thereof. 4. The method of claim 1 , wherein said human keratinous tissue is human skin. 5. The method of claim 1 , wherein said human keratinous tissue is human scalp. 6. The method of claim 1 , wherein said human keratinous tissue is human nails. 7. The method of claim 1 , wherein said human keratinous tissue is human hair. 8. A method of regulating the condition of human keratinous tissue, consisting of orally administering a probiotic strain of Bifidobacteria to a human seeking said regulation. 9. A method of regulating the condition of human keratinous tissue, comprising orally administering a probiotic strain of Bifidobacteria to a human seeking said regulation at a dose of at least about 2 grams per day. 10. A method of regulating the condition of human keratinous tissue, comprising orally administering a probiotic strain of Bifidobacteria to a human seeking said regulation, wherein the probiotic strain of Bifidobacteria is contained in a unit dose form within a sachet.
Assignees
Inventors
Classifications
from microorganisms other than algae or fungi, e.g. protozoa or bacteria · CPC title
using bacteria or actinomycetales · CPC title
Preparations for care of the skin · CPC title
Bifidobacteria · CPC title
Drugs for dermatological disorders · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US8926952B2 cover?
- Methods of use in humans of probiotic bacteria of the genus Bifidobacteria for regulating the condition of human keratinous tissue to achieve cosmetic beauty benefits. Said methods include regulation, either prophylactic or therapeutic, of the cosmetic appearance of human keratinous tissue, such as human hair, skin (e.g., scalp), and nails. In another aspect, the invention provides a method o…
- Who is the assignee on this patent?
- Trejo Amy Violet, O'Mahony Liam Diarmuid, Procter & Gamble, and 1 more
- What technology area does this patent fall under?
- Primary CPC classification A23L33/135. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Jan 06 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).